FDA approves AstraZeneca and Ionis’ treatment for ATTR polyneuropathy
AstraZeneca and Ionis have received FDA approval for Waiuna, their treatment for polyneuropathy in life-threatening disease transthyretin-mediated amyloidosis (ATTR).
Archives for January 4, 2024
Shorla Oncology and Eversana announce US launch of first oral methotrexate solution
Irish pharmaceutical company Shorla Oncology and consultancy firm Eversana have announced the U.S. launch of JYLAMVO, the first oral methotrexate solution.
Casgevy approval unlikely to be followed up by another CRISPR drug in near future
Vertex Pharmaceuticals and CRISPR Therapeutics made history last month by gaining approval for the first CRISPR-based drug, Casgevy.